Screening
|
Who needs it
|
How often
|
Alcohol misuse
|
All adults
|
At routine exams
|
Blood pressure
|
All adults
|
Every 2 years if your blood pressure is less than 120/80 mm Hg; yearly if your systolic blood pressure is 120 to 139 mm Hg, or your diastolic blood pressure reading is 80 to 89 mm Hg
|
Breast cancer
|
All women in this age group should talk with their healthcare providers about breast self-awareness
|
At routine exams
Our breast health task force has a more stringent recommendation. Please see our SCL Health mammography screening guidelines.
|
Cervical cancer
|
Women ages 21 and older
|
Women between ages 21 and 29 should have a Pap test every 3 years; women between the ages 30 and 65 should have a Pap test plus an HPV test every 5 years.
|
Depression
|
All women in this age group
|
At routine exams
|
Diabetes mellitus, type 2
|
Adults with no symptoms who are overweight or obese and have 1 or more additional risk factors for diabetes
|
At least every 3 years (annual testing if blood sugar has begun to rise)
|
Hepatitis C
|
Anyone at increased risk for infection
|
At routine exams
|
HIV
|
All women
|
At routine exams
|
Obesity
|
All adults
|
At routine exams
|
Tuberculosis
|
Anyone at increased risk for infection
|
Check with your healthcare provider
|
Vision
|
Women in this age group(1)
|
Every 5 to 10 years if not risk factors for eye disease
|
Counseling
|
Who needs it
|
How often
|
Breast cancer, chemoprevention
|
Women at high risk
|
When risk is identified
|
BRCA mutation testing for breast and ovarian cancer susceptibility
|
Women with increased risk
|
When risk is identified
|
Diet and exercise
|
Women who are overweight or obese
|
When diagnosedand at routine exams
|
Domestic violence
|
Women at the age in which they are able to have children
|
At routine exams
|
Skin cancer
|
Prevention of skin cancer in fair-skinned adults through age 24
|
At routine exams
|
Tobacco use and tobacco-related disease
|
All adults
|
Every exam
|
Immunizations***
|
Who needs it
|
How often
|
Human papillomavirus (HPV)
|
All women in this age group up to age 26
|
3 doses
The second dose should be given 1 to 2 months after the first dose, and the third dose should be given 6 months after the first dose
|
Tetanus/diphtheria/pertussis (Td/Tdap) booster
|
All adults
|
Td: every 10 years
Tdap: substitute a one-time dose of Tdap for a Td booster after age 18, then boost with Td every 10 years
|
Chickenpox (varicella)
|
All adults in this age group who have no record of previous infection or vaccinations
|
2 doses; the second dose should be given 4 to 8 weeks after the first dose
|
Measles, mumps, rubella (MMR) vaccine
|
All adults in this age group who have no record of previous infection or vaccinations
|
1 or 2 doses
|
Flu vaccine (seasonal)
|
All adults
|
Yearly, when the vaccine becomes available in the community
|
Haemophilus influenzaeType B (HIB)
|
Women at increased risk for infection – talk with your healthcare provider
|
1 to 3 doses
|
Hepatitis A vaccine
|
People at risk (2)
|
2 doses given at least 6 months apart
|
Hepatitis B vaccine
|
People at risk (3)
|
3 doses; second dose should be given 1 month after the first dose; the third dose should be given at least 2 months after the second dose (and at least 4 months after the first dose)
|
Meningococcal
|
People at risk (4)
|
1 or more doses
|
Pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharidevaccine(PPSV23)
|
People at risk (5)
|
PCV13: 1 dose ages 19 to 65 (protects against 13 types of pneumococcal bacteria)
PPSV23: 1 to 2 doses through age 64, or 1 dose at 65 or older (protects against 23 types of pneumococcal bacteria)
|